Cardurion logo - click to return to the homepage

the Course of
Cardiovascular Disease

We translate our
world-class expertise

in cardiovascular signaling pathways into groundbreaking therapeutics for patients.

Discover new targets and novel drug candidates

Innovate using adaptive trial designs and precision medicine approaches

Acquire assets where we have unique insights into their use in CV disease

A Next Generation
Cardiovascular Company

We are addressing the continuing unmet needs of patients with cardiovascular disease through:

Groundbreaking clinical programs in PDE9 and CaMKII inhibition

Experienced team of CV experts and industry veterans with track records of success

Strategic portfolio approach driven by an in-house drug discovery group and a highly experienced search and evaluation team

Foundational partnerships with key strategics and investors, including an investment by Bain Capital to support current programs and pipeline expansion


We are advancing Two Groundbreaking Clinical Programs  

Heart Failure: PDE9

PDE9 inhibition presents an opportunity to develop a foundational new treatment for patients with both types of chronic heart failure, HFrEF and HFpEF, with the potential for improved efficacy when added to guideline-directed medical therapy. 

Rare arrhythmias and more common CV Diseases: CaMKII

CaMKII plays a critical role in regulating normal calcium signaling and cardiac function. CaMKII has a causal role in a number of cardiac diseases when it becomes hyperactivated. 

Cardurion is the first company to successfully develop a CaMKII inhibitor and evaluate it in clinical studies. We are now well positioned to explore multiple cardiovascular diseases, including the rare and fatal genetic disease catecholaminergic polymorphic ventricular tachycardia (CPVT), as well as larger indications including heart failure and atrial fibrillation.


News and Events

Keep up to date with the latest Cardurion news.


Learn more about the science behind Cardurion’s research and development.

Contact Us

To request additional information or contact us, please fill out the contact form. 


78 Blanchard Road
Suite 200
Burlington, MA 01803, USA


Cardurion Pharmaceuticals KK
26-1, Muraoka-Higashi 2-chome,
Fujisawa, Kanagawa 251-8555, Japan 

Media Contact

This field is for validation purposes and should be left unchanged.

This site uses cookies and third-party scripts to provide certain services. View Privacy Policy

Skip to content